Opthea Limited Sponsored ADR (OPT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Opthea Limited, a biopharmaceutical company focused on innovative treatments for retinal diseases, will engage with investors at the Citi 2024 Global Healthcare Conference. CEO Fred Guerard will lead discussions on Opthea’s advancements, highlighting their Phase 3 trials aimed at enhancing treatment efficacy for conditions like wet age-related macular degeneration.
For further insights into OPT stock, check out TipRanks’ Stock Analysis page.
